
VAC2VAC provided vital evidence to demonstrate that non-animal alternatives can reliably detect certain contaminants in medicines administered by injection.
VAC2VAC provided vital evidence to demonstrate that non-animal alternatives can reliably detect certain contaminants in medicines administered by injection.
We publish the draft topics ahead of the call launch to give applicants extra time to start preparing a proposal and building a consortium.
We publish the draft topics ahead of the call launch to give applicants extra time to start networking and preparing a proposal.
Combatting antimicrobial resistance: the legacy of the IMI COMBACTE projects
IHI took part in this year’s BIO International Convention which was held in San Diego, US on 3-6 June.
Tuberculosis (TB) is the world’s second leading killer infectious disease after COVID-19, wiping out 1.3 million people in 2022. Unfortunately, more and more patients with...
IHI call 5 is a single-stage call with topics on the 3Rs, theranostics, stroke management and synthetic data.
The app, developed by IMI project eTRANSAFE, makes it easier for researchers to analyse which biomarkers are being used in which clinical studies.
The topics cover subjects as diverse as cutting animal testing in research, sustainability in healthcare, rare diseases, and equitable access to clinical research.
The topics cover subjects as diverse as sustainability in healthcare, rare diseases, and equitable access to clinical research. Registration for the IHI Call Days is also open.